Home > 2019 > March > 06

The US FDA approves ketamine-derived depression drug

The US Food and Drug Administration has approved a replacement depression drug, esketamine, for patients United Nations agency haven't older alternative antidepressants. The treatment, a nasal spray associated with the party drug ketamine hydrochloride, are the primary fast-acting depression drug on the market. Unlike most older antidepressants, esketamine lifts patients’ moods

Read More